Core Laboratories
CLB
#5561
Rank
NZ$1.63 B
Marketcap
$34.74
Share price
-3.42%
Change (1 day)
9.93%
Change (1 year)

P/E ratio for Core Laboratories (CLB)

P/E ratio as of November 2024 (TTM): 41.3

According to Core Laboratories 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 41.3454. At the end of 2022 the company had a P/E ratio of 48.9.

P/E ratio history for Core Laboratories from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202248.9-6.25%
202152.1-531.86%
2020-12.1-173.45%
201916.4-50.44%
201833.2-43.07%
201758.2-29.05%
201682.1103.37%
201540.495.36%
201420.7-42.29%
201335.849.5%
201223.9-16.35%
201128.63.85%
201027.615.07%
200924.0121.34%
200810.8-55.3%
200724.2-1.64%
200624.6-20.92%
200531.1-36%
200448.683.62%
200326.5-128.01%
2002-94.6-525.02%
200122.3

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
14.8-64.20%๐Ÿ‡บ๐Ÿ‡ธ USA
37.1-10.27%๐Ÿ‡บ๐Ÿ‡ธ USA
10.1-75.52%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
73.2 77.08%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.